Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Vaccine

• Publication date

  2000-01-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(99)00391-6PMID 10649624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

  1999cited by this paper
• Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

  1998cited by this paper
• Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

  1998cited by this paper
• Help for cytotoxic-T-cell responses is mediated by CD40 signalling

  1998cited by this paper
• Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.

  1998cited by this paper
• CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

  1997cited by this paper
• Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

  1997cited by this paper
• Rapid Effector Function in CD8+ Memory T Cells

  1997cited by this paper
• Adjuvants--a classification and review of their modes of action.

  1997cited by this paper
• Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

  1997cited by this paper
• HIV‐1‐specific cell‐mediated immune responses induced by DNA vaccination were enhanced by mannan‐coated liposomes and inhibited by anti‐interferon‐γ antibody

  1997cited by this paper
• In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.

  1997cited by this paper
• Liposome‐mediated DNA vaccination

  1997cited by this paper
• DNA vaccines.

  1997cited by this paper
• DNA vaccines -- a modern gimmick or a boon to vaccinology?

  1997cited by this paper
• Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

  1997cited by this paper
• Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.

  1997cited by this paper
• Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1

  1997cited by this paper
• The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.

  1997cited by this paper
• In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.

  1997cited by this paper
• Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.

  1997cited by this paper
• Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

  1997cited by this paper
• Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization.

  1997cited by this paper
• HIV‐1‐specific cell‐mediated immunity is enhanced by co‐inoculation of TCA3 expression plasmid with DNA vaccine

  1997cited by this paper
• Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.

  1996cited by this paper
• DNA immunization against experimental genital herpes simplex virus infection.

  1996cited by this paper
• Gene vaccination with naked plasmid DNA: mechanism of CTL priming

  1996cited by this paper
• Induction of TH1 and TH2 Immunity in Neonatal Mice

  1996cited by this paper
• Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.

  1995cited by this paper
• Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.

  1995cited by this paper
• Vaccine Design

  1995cited by this paper
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

  1995cited by this paper
• Structure and properties of aluminum-containing adjuvants.

  1995cited by this paper
• Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

  1993cited by this paper
• Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Genetic immunization is a simple method for eliciting an immune response

  1992cited by this paper
• Preparation and use of calcium phosphate adsorbed vaccines.

  1986cited by this paper
• Preparation and use of calcium phosphate adsorbed vaccines.

  1986cited by this paper
• Current status of immunological adjuvants.

  1986cited by this paper
• A computer program for the evaluation of ELISA data obtained using an automated microtiter plate absorbance reader.

  1984cited by this paper
• Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains.

  1980cited by this paper
• STUDIES ON ANTIBODY PRODUCTION

  1955cited by this paper

• Advances in nucleic acid-based cancer vaccines

  2025cites this paper
• Co‐delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1‐dominant humoral and cellular immunity against SARS‐CoV‐2

  2023cites this paper
• Research Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms

  2023cites this paper
• The development of DNA vaccines against SARS-CoV-2

  2023cites this paper
• Metal-based nano-vaccines for cancer immunotherapy

  2022cites this paper
• Preclinical study of a DNA vaccine targeting SARS-CoV-2

  2022cites this paper
• Safety and preservation of cardiac function following therapeutic vaccination against Trypanosoma cruzi in rhesus macaques

  2022cites this paper
• Development of nano-carriers for Leishmania vaccine delivery

  2020cites this paper
• Preclinical study of DNA vaccines targeting SARS-CoV-2

  2020cites this paper
• Calcium phosphate: a substitute for aluminum adjuvants?

  2017cites this paper
• Saccharomyces boulardii improves humoral immune response to DNA vaccines against leptospirosis

  2017cites this paper
• Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems

  2016cites this paper
• For t 2 DNA vaccine prevents Forcipomyia taiwana (biting midge) allergy in a mouse model

  2016cites this paper
• Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases

  2015cites this paper
• Engineered biomaterials for development of nucleic acid vaccines

  2015cites this paper
• Aluminum-Induced Entropy in Biological Systems: Implications for Neurological Disease

  2014cites this paper
• The Production of Plasmid DNA Vaccine in Escherichia coli: A Novel Bacterial‐Based Vaccine Production Platform

  2014cites this paper
• Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity☆

  2014cites this paper
• Identification of an HIV-1 Clade A Envelope That Exhibits Broad Antigenicity and Neutralization Sensitivity and Elicits Antibodies Targeting Three Distinct Epitopes

  2013cites this paper
• A Conserved Region of Leptospiral Immunoglobulin-Like A and B Proteins as a DNA Vaccine Elicits a Prophylactic Immune Response against Leptospirosis

  2013cites this paper
• Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice.

  2013cites this paper
• Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.

  2013cites this paper
• Enhanced potency of replicon vaccine using one vector to simultaneously co-express antigen and interleukin-4 molecular adjuvant

  2013cites this paper
• Immune Responses to DNA Vaccines: Induction of CD8 T Cells

  2013cites this paper
• Technologies for enhanced efficacy of DNA vaccines

  2012cites this paper
• An endogenous immune adjuvant released by necrotic cells for enhancement of DNA vaccine potency.

  2012cites this paper
• Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii

  2012cites this paper
• Controlled growth of calcium phosphate using phosphatidylcholine-modified porous titania as reaction compartments

  2012cites this paper
• Hemokinin-1 As an Adjuvant Molecule Enhancing Humoral and Memory Responses to HBsAg DNA Vaccination

  2012cites this paper
• Plasmid DNA production for therapeutic applications.

  2012cites this paper
• DESIGNING AND CONSTRUCTION OF BICISTRONIC PLASMID PIRES-IGK/MIL18/FC: POTENTIAL IMPLICATIONS FOR VACCINE INVESTIGATIONS

  2011cites this paper
• Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant

  2011cites this paper
• Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.

  2010cites this paper
• Chitosan-based nanoparticles for improving immunization against hepatitis B infection.

  2010cites this paper
• Enhanced potency of individual and bivalent DNA replicon vaccines or conventional DNA vaccines by formulation with aluminum phosphate.

  2010cites this paper
• Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route.

  2010cites this paper
• Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.

  2009cites this paper
• Calcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virus.

  2009cites this paper
• A review of multiple approaches towards an improved hepatitis B vaccine

  2009cites this paper
• Leishmania homologue of receptors for activated C kinase (LACK)

  2009cites this paper
• In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing Hepatitis B surface antigen and Interleukin-2

  2009cites this paper
• CLONING AND SEQUENCING OF L. MAJOR LEISHMANIA HOMOLOGUE OF RECEPTORS FOR ACTIVATED C KINASE (LACK) GENE

  2008cites this paper
• Development of a Highly Productive and Scalable Plasmid DNA Production Platform

  2008cites this paper
• EVALUATION OF BAX ENCODING PLASMID FOR INCREASING EFFICACY OF DNA VACCINE PLASMID ENCODING GB OF HERPES SIMPLEX VIRUS TYPE 1

  2008cites this paper
• Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.

  2008cites this paper
• Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation

  2007cites this paper
• Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS

  2007cites this paper
• Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

  2007cites this paper
• Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.

  2007cites this paper
• Fusion of antigen to Fas-ligand in a DNA vaccine enhances immunogenicity.

  2007cites this paper
• Development of a therapeutic vaccine against the hepatitis C virus

  2007cites this paper
• Comparison of immunogenicity of Aluminum salts as adjuvant for recombinant Hepatitis-B vaccine

  2006cites this paper
• DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.

  2006cites this paper
• Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA.

  2006cites this paper
• Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens.

  2006cites this paper
• Lipid microparticles for mucosal immunization against hepatitis B.

  2006cites this paper
• Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana.

  2005cites this paper
• The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine.

  2005cites this paper
• An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming.

  2005cites this paper
• Local and Systemic Immune Responses to Intratracheal Instillation of Antigen and DNA Vaccines in Mice

  2004cites this paper
• Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization

  2004cites this paper
• Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines.

  2004cites this paper
• From Microbiology and Tumor Biology Center (MTC), Karolinska Institutet and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

  2004cites this paper
• Concepts in DNA immunization overcoming viral diversity and enhancing plasmid immunogenicity

  2004cites this paper
• Recombinant Gene Expression

  2004cites this paper
• Optimization of DNA-based vaccination in cows using green fluorescent protein and protein A as a prelude to immunization against staphylococcal mastitis.

  2003cites this paper
• A pattern matching algorithm for codon optimization and CpG motif-engineering in DNA expression vectors

  2003cites this paper
• Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.

  2003cites this paper
• Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles.

  2003cites this paper
• Codon Optimization for DNA Vaccines and Gene Therapy Using Pattern Matching

  2003cites this paper
• Adjuvant synergy in the response to hepatitis B vaccines.

  2003cites this paper
• Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response

  2003cites this paper
• Vesicular systems for non-invasive topical immunization: Rationale and prospects

  2002cites this paper
• Current status of DNA vaccines and their route of administration.

  2002cites this paper
• Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.

  2002cites this paper
• Mechanisms of stimulation of the immune response by aluminum adjuvants.

  2002cites this paper
• Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV).

  2002cites this paper
• Additives and protein-DNA combinations modulate the humoral immune response elicited by a hepatitis C virus core-encoding plasmid in mice.

  2002cites this paper
• Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens.

  2001cites this paper
• Flavivirus DNA vaccines: current status and potential.

  2001cites this paper
• A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice.

  2001cites this paper
• Lysine: Is it worth more?

  2001cites this paper
• Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates

  2001cites this paper
• Recent Advances in the Development of Peptide Vaccines for Hepatitis B

  2001cites this paper
• Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization.

  2001cites this paper
• Optimization Strategies for DNA Vaccines

  2001cites this paper
• Flavivirus DNA Vaccines

  2001cites this paper
• Different HBs Antibody versus Lymphoproliferative Responses after Application of a Monovalent (Hepatitis B) or Combined (Hepatitis A + Hepatitis B) Vaccine

  2000cites this paper
• Immunogenicity of a hexavalent combination vaccine in rhesus monkeys.

  2000cites this paper
• Production and delivery of recombinant subunit vaccines

  2000cites this paper
• Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer

  2000cites this paper
• Intramuscular Electrical Gene Transfer to a Hepatitis C Virus E 2 DNA Vaccine by Enhancing Band T-Cell Immune Response

  2000cites this paper